— AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected.
— Net sales remained flat at $70 million, vs. $71.2 million expected.
— US net sales grew 1.8% to $55.6 million.
— International net sales increased 5.6% to $14.4 million.
— Oncology net sales rose 5.1% to $16.1 million.
— Vascular Interventions and Therapies net sales grew 0.6% to $31.2 million.
— Vascular Access net sales fell 4% to $22.8 million.
— FY2020 net sales are expected to be $280-286 million.
— FY2020 adjusted EPS is expected to be $0.10-0.15.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
AMAT Earnings: Applied Materials Q1 2025 adj. profit rises on higher sales
Applied Materials, Inc. (NASDAQ: AMAT), a leading supplier of equipment and software for manufacturing semiconductor chips and flat panel displays, Thursday reported an increase in sales and adjusted earnings for
Cisco Systems (CSCO) bets on strong AI demand to drive growth
After starting the fiscal year on a weak note, Cisco Systems Inc. (NASDAQ: CSCO) has regained momentum, reporting higher second-quarter revenue and profit that beat analysts’ estimates. The company is
What to expect when Hasbro (HAS) reports its fourth quarter 2024 earnings results
Shares of Hasbro, Inc. (NASDAQ: HAS) stayed green on Thursday. The stock has gained 7% year-to-date. The toymaker is scheduled to report its fourth quarter 2024 earnings results on Thursday,
